BAC vs DHR: Which Is the Better Buy?
Side-by-side comparison of Bank of America Corporation and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
Bank of America Corporation · Financial Services
$53.95
-36.2% upside to fair value
Grade C
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
DHR has more upside to fair value
(+13.2%).
BAC trades at a lower forward P/E
(12.3x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BAC |
DHR |
| Current Price |
$53.95 |
$174.04 |
| Fair Value Estimate |
$34.41 |
$197.01 |
| Upside to Fair Value |
-36.2%
|
+13.2%
|
| Market Cap |
$387.2B |
$123.2B |
| Forward P/E |
12.3x
|
33.4x
|
| EV / EBITDA |
12.7x
|
20.3x
|
| Price / Sales |
2.2x
|
5.0x
|
| Price / FCF |
30.7x
|
23.3x
|
| Revenue Growth YoY |
-35.6%
|
+3.7%
|
| Gross Margin |
63.2%
|
60.7%
|
| Operating Margin |
22.9%
|
21.0%
|
| Return on Equity |
10.5%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
3.26%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Bank of America Corporation is a leading diversified bank with $3.41 trillion in assets and a broad footprint across consumer banking, global markets, wealth management, and corporate banking. The company benefits from a strong market position and experienced leadership under CEO Brian T. Moynihan. However, the stock is currently overvalued, trading approximately 36% above its fair value estimate…
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
BAC |
DHR |
| Zone Low |
$25.81 |
$147.76 |
| Zone High |
$29.25 |
$167.46 |
| In Buy Zone? |
No
|
No
|